THE RAPID PROGRESS OF THE NPWT SECTOR AND THE EXIT OF JOHNSON & JOHNSON AND BRISTOL-MYERS SQUIBB HAS CHANGED THIS SECTOR FUNDAMENTALLY. WHO ARE THE PLAYERS AND TECHNOLOGIES THAT ARE BENEFITING FROM THESE DEVELOPMENTS?
Key Areas Addressed:
Growth forecasts to 2013 for the major moist wound care, NPWT and biological wound care sectors and regions
Market share data by company for major product sectors
An examination of market and product growth drivers
Extensive review of product ranges within each wound care sector
Competitor reviews of 115 leading and developing companies
While the advanced wound care market has generally seen double-digit growth over the past five years, the growth rate slowed in 2008 and this trend is expected to continue in 2009 with a global valuation of US$4.9 billion in 2008.
The number of patients requiring treatments for chronic and challenging wounds has and will continue to rise. However, growth in terms of sales volumes is being affected by the higher number of companies entering this market, which is increasing competition and bringing down selling prices. In addition, the market is likely to see pressures on reimbursement levels as governments seek to rein in healthcare expenditure during the current economic downturn.
While several leading companies have added to their advanced wound care portfolios, two leading healthcare companies have exited this market: Johnson & Johnson (via Ethicon) and Bristol-Myers Squibb (via ConvaTec). For both companies, advanced wound care was not a key part of their overall operations and the move may have been timely, as market growth is slowing in their sector of interest and neither company had a presence in the rapidly-growing field of NPWT.
Focus on the key issues and trends
Private equity adds a new dimension to the market
Other manufacturers did not benefit from the decision of J&J and BMS to exit the market; both ConvaTec and the Johnson & Johnson Professional Wound Care business were purchased by private equity firms.
The Johnson & Johnson Professional Wound Care business became Systagenix Wound Management in December 2008 following One Equity Partners’ acquisition of the business. ConvaTec became a separate entity from Bristol-Myers Squibb in August 2008 following its sale to new owners, Nordic Capital and Avista Capital Partners, in a deal valued at US$4.1 billion. A month after the transition, in September 2008, ConvaTec acquired Unomedical, a Danish manufacturer of hospital products and infusion devices, from Nordic Capital Fund IV. The combined company, which retains the ConvaTec name, has approximately 8,000 employees and annual revenue in the region of US$1.6 billion.
Negative Pressure Wound technology continues to take market share as companies position themselves for growth
Expected to exceed US$2 billion by 2013, NPWT technology is continuing to gain ground and is taking market share from moist wound care products. Many of the leaders in other areas of advanced wound care have seen their market share decline.
This is expected to continue as NPWT is expanded into currently under-penetrated geographic regions and for use in new indications and healthcare environments. In response, several of the traditional wound care market leaders have entered or plan to enter the NPWT market. Notably, Smith & Nephew (S&N) acquired BlueSky Medical in 2007, Getinge launched a NPWT system in 2008 following its acquisition of Huntleigh Technology and Mölnlycke is also looking into this area. In addition, ConvaTec has recently gained a presence in the NPWT market through an exclusive global agreement for Boehringer Technologies’ Engenex NPWT system.
While there is clearly increased competition for NPWT, there are certain barriers to developing a presence in this market. The market model involves the rental of NPWT devices to healthcare providers and the sale of disposables. This model requires companies to have the capabilities to deliver and collect the rental products, either themselves or through partners, which could be a major hindrance to companies wanting to enter the NPWT market.
Regional Sales: A tale of two technologies
The advanced wound care market is currently dominated by the European region, which accounted for 41% of the total sales volumes in the market in 2008. In addition, the US represented 39% of the market and the rest of the world 20.5%. However, the adoption of different types of advanced wound care technologies differs between these regions, with Europe and the rest of the world more broadly adopting moist wound care dressings and the US being the largest market for NPWT. Currently, Espicom estimates that around 70% of the NPWT market is in the US and only 30% is in the international market, providing continued growth potential for NPWT outside the US. However, for moist wound care, over 50% of the market is in Europe and only around 25% in the US.
About the author
This report has been written by Joanne Tibballs, an experienced Espicom researcher and former editor of Medical Device Companies Analysis. In addition to this report she has written Medical IT: Understanding the major players and products and The Executive Guide to Molecular Imaging.
Just some of the 115 companies profiled
THE MARKET LEADERS
- Hartmann Group
- Kinetic Concepts
- Medline Industries
- Mölnlycke Health Care
- Smith & Nephew
- Systagenix Wound Management
OTHER COMPANIES INCLUDE
- AGT Sciences
- Argentum Medical
- Aspen Surgical Products
- Avita Medical
- B. Braun
- Biotec Pharmacon
- Boehringer Laboratories
- Care-Tech Laboratories
- Collagen Matrix
- DermaRite Industries
- Dr Suwelack Skin & Health Care
- Fidia Advanced Biopolymers
- First Water
- Forticell Bioscience
- Genadyne Biotechnologies
- Genzyme Biosurgery
- HemCon Medical Technologies
- Hollister Wound Care
- Innocoll and CollMED Laboratories
- Innovative Therapies
- Integra LifeSciences Holdings
- Ivivi Technologies
- IYIA Technologies
- Kalypto Medical
- Medestea Internazionale
- Nucryst Pharmaceuticals
- Oculus Innovative Sciences
- Oxygen Biotherapeutics
- Pegasus Biologics
- Premco Medical Systems
- Quick-Med Technologies
- RegeneRx Biopharmaceuticals
- Regenesis Biomedical
- SanoMed Manufacturing
- Southwest Technologies
- TGR BioSciences
- Tissue Genesis
- Tissue Regeneration Technologies
- Vibrant Medical
- York Pharma